Brett Sandercock

2012

In 2012, Brett Sandercock earned a total compensation of $2.3M as Chief financial officer at ResMed, a 1% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$488,944
Salary$510,517
Stock Awards$1,260,820
Other$44,446
Total$2,304,728

Sandercock received $1.3M in stock awards, accounting for 55% of the total pay in 2012.

Sandercock also received $488.9K in non-equity incentive plan, $510.5K in salary and $44.4K in other compensation.

Rankings

In 2012, Brett Sandercock's compensation ranked 3,083rd out of 11,487 executives tracked by ExecPay. In other words, Sandercock earned more than 73.2% of executives.

ClassificationRankingPercentile
All
3,083
out of 11,487
73rd
Division
Manufacturing
1,075
out of 4,252
75th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
126
out of 619
80th
Industry group
Surgical, Medical, And Dental Instruments And Supplies
70
out of 360
81st
Industry
Surgical and Medical Instruments and Apparatus
38
out of 215
82nd
Source: SEC filing on October 2, 2014.

Sandercock's colleagues

We found four more compensation records of executives who worked with Brett Sandercock at ResMed in 2012.

2012

Peter Farrell

ResMed

Chairman

2012

Rob Douglas

ResMed

Chief Operating Officer

2012

Robert Douglas

ResMed

Chief Operating Officer

2012

David Pendarvis

ResMed

Chief Administrative Officer

News

You may also like